Unknown

Dataset Information

Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity.


ABSTRACT: There are no blood-based biomarkers distinguishing patients with relapsing-remitting (RRMS) from secondary progressive multiple sclerosis (SPMS) although evidence supports metabolomic changes according to MS disease severity. Here machine learning analysis of serum metabolomic data stratified patients with RRMS from SPMS with high accuracy and a putative score was developed that stratified MS patient subsets. The top differentially expressed metabolites between SPMS versus patients with RRMS included lipids and fatty acids, metabolites enriched in pathways related to cellular respiration, notably, elevated lactate and glutamine (gluconeogenesis-related) and acetoacetate and bOHbutyrate (ketone bodies), and reduced alanine and pyruvate (glycolysis-related). Serum metabolomic changes were re

SUBMITTER: Oppong AE 

PROVIDER: S-EPMC10907838 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature